We are building a platform of bacterial molecules to awaken our body’s innate ability to control inflammation and heal. Our first indication is Crohn’s Disease, which affects over 500,000 Americans at an annual cost of $10B. After Crohn's disease, we are going for type 1 Diabetes and Multiple Sclerosis.
Promakhos Therapeutics is dedicated to developing curative therapies that restore the immune system's function, enabling the body to control inflammation and heal. Founded in 2021 and based in Allston, Massachusetts, our mission is to address the root causes of chronic inflammatory diseases by restoring immune balance rather than suppressing it.
Promakhos Therapeutics is currently in the research and development phase, with funding and grants supporting our innovative projects. Pricing for future therapies will be determined as we progress through clinical trials and regulatory approvals.
Promakhos Therapeutics is led by a team of distinguished professionals:
Our strategic advisors include renowned experts in gastroenterology, drug discovery, and regulatory affairs, ensuring that our research and development efforts are guided by the best minds in the field.
Promakhos Therapeutics is committed to transforming the treatment of chronic inflammatory diseases by harnessing the body's natural ability to heal. Join us on our journey to make a lasting impact on global health.
Match with like-minded professionals for 1:1 conversations
Go from Slack Chaos to Clarity in Minutes
Personalize 1000s of landing pages in under 30 mins
The first LLM for document parsing with accuracy and speed
AI Assistants for SaaS professionals
AI-powered phone call app with live translation
Delightful AI-powered interactive demos—now loginless
AI Motion Graphics Copilot
Pop confetti to get rid of stress & anxiety, 100% AI-free
Smooth payments for SaaS